PharmaRadar360

PharmaRadar360

馃嚭馃嚫路13h agoRegulatoryTier 1 路 Regulatory source

Modification of Living Organ Donation Reimbursement Program Eligibility Guidelines in Response To Honor Our Living Donors Act

On July 1, 2026, HRSA published a notice in the Federal Register to solicit comments on proposed mod...

Publisher

F
Federal Register

USA

This page provides a limited summary, publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.

Read original

At a glance

Publisher
Federal Register
Region
USA
Scope
Regulatory
Published
September 29, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Summary excerpt

On July 1, 2026, HRSA published a notice in the Federal Register to solicit comments on proposed mod...

Source route

Continue on federalregister.gov

Leave the platform to read the original full article on the publisher site.

Source: Federal Register

Scope: Regulatory

Evidence: Tier 1 路 Regulatory source

Open original article
Modification of Living Organ Donation Reimbursement Program Eligibility Guidelines in Response To Honor Our Living Donors Act | PharmaRadar360